Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia
B-cell chronic lymphocytic leukaemia (B-CLL) remains an incurable disease due to the high risk of relapse, even after complete remission, raising the need to control and eliminate residual tumor cells in long term. Adoptive T cell therapy with genetically engineered specificity is thought to fulfil...
Shranjeno v:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2012-01-01
|
| Serija: | Advances in Hematology |
| Online dostop: | http://dx.doi.org/10.1155/2012/595060 |
| Oznake: |
Brez oznak, prvi označite!
|